Delivery Order SPE2DR25D1022-SPE2DR26FQP2E
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,939.04 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel in 45-gram units. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,512.56 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram quantities, with a ceiling value of $1,073.57. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract...
- The Defense Logistics Agency awarded a $6,904.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram quantities. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $1,364.53 delivery order to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel 60GM, a topical antifungal medication. This firm fixed price, non-set-aside contract is scheduled for completion by September 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,961.53 to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside delivery order under DLA's pharmaceutical supply chain. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, valued at $2,502.11. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract was executed with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,182.95 of Naftifine HCL 1% Cream (60GM) with an ultimate completion date of October 29, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single-line item pharmaceutical procurement supporting federal medical supply needs. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units with a ceiling value of $4,706.55. This competitively awarded, firm fixed-price delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The contract carries no set-aside designation, and performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $3,266.05 to AmerisourceBergen Drug Corp for the supply of Naftifine HCL 1% Cream in 60-gram units. This is a competitively awarded, non-set-aside contract with firm fixed pricing and a completion date of October 21, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a delivery order, this award represents a single task issued against a larger contract...
- SPE2DR25D1022Indefinite Delivery Contract
- SPE2DR25D1022-SPE2DR26FQP2EDelivery Order
The Defense Logistics Agency awarded a $2,305.26 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Naftifine HCL 2% Gel in 60-gram quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of November 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle valued through December 2026 that enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling military medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This delivery order represents a routine pharmaceutical procurement supporting the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 11/3/25 |